Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR

BMC Cancer

Chanvilay SICHANH³  Fabrice QUET⁴  Phetsavanh CHANTHAVILAY²  Joeffroy DIENDERE³  Vatthanaphone LATTHAPHASAVANG¹  Christophe LONGUET⁵  Yves BUISSON³ 

[1] Department of Infectious Diseases, Mahosot hospital, Vientiane, Lao PDR

[2] University of Health Sciences, Vientiane, Lao PDR

[3] Institut de la Francophonie pour la Médecine Tropicale (IFMT), Vientiane, Lao PDR

[4] UMR 1094 (Université de Limoges/Inserm/CHU de Limoges) Neuroépidémiologie Tropicale (NET), Limoges, France

[5] Fondation Mérieux, Lyon, France

关键词: Lao PDR;    Attitude;    Awareness;    Knowledge;    HIV/AIDS;    Cervical cancer screening;   

Others  :  858995
DOI  :  10.1186/1471-2407-14-161

 received in 2013-07-18, accepted in 2014-02-26,  发布年份 2014

【 摘 要 】

Background

Cervical cancer is the first female cancer in Lao PDR, a low-income country with no national screening and prevention programs for this human papillomavirus (HPV) associated pathology. HIV-infected women have a higher risk of persistent oncogenic HPV infection.

The purpose of this study was to determine the knowledge, awareness and attitudes about cervical cancer among Lao women attending or not an HIV treatment center, in order to understand if this attendance had offered an opportunity for information and prevention.

Methods

A cross-sectional case–control survey was conducted in three provinces of Lao PDR, Vientiane, Luang Prabang and Savannakhet. Cases were 320 women aged 25 to 65, living with HIV and followed in an HIV treatment center. Controls were 320 women matched for age and place of residence, not attending an HIV treatment center.

Results

Cases had a greater number of sexual partners and used condoms more often than controls. Only 36.6% of women had consulted a gynecologist (47.5% among cases and 25.6% among controls, p < 0.001) and 3.9% had benefited from at least one Pap smear screening (5.6% cases and 2.2% controls, p = 0.02). The average knowledge score was 3.5 on a 0 to 13 scale, significantly higher in cases than in controls (p < 0.0001). Despite having a lower education level and economic status, the women living with HIV had a better knowledge about cervical cancer and were more aware than the controls of the risk of developing such a cancer (35.9% vs. 8.4%, p = 0.0001). The main source of information was healthcare professionals. The main reasons for not undergoing Pap smear were the absence of symptoms and the default of medical injunction for cases, the lack of information and ignorance of screening usefulness for controls.

Conclusion

In Lao PDR, routine consultation in HIV treatment centers is not enough harnessed to inform women of their high risk of developing cervical cancer, and to perform screening testing and treatment of precancerous lesions. Implementing this cost-effective strategy could be the first step toward a national prevention program for cervical cancer.

【 授权许可】

   
2014 SICHANH et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD: Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 2002, 94:1469-1483.
• [2]zur Hausen H: Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.
• [3]Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008, 43(4 Suppl):S5-S25.
• [4]Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
• [5]Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, Coombs R: Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women’s HIV Interdisciplinary Network (WHIN). Int J Infect Dis 2010, 14:e810-e814.
• [6]Sun X-W, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr: Human Papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343-1349.
• [7]Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat N: Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003, 188:555-563.
• [8]Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Putignano G: Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 2005, 121:226-232.
• [9]Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E, Tuijn C, Wit FW, Umutoni A, Uwineza M, Crucitti T, van de Wijgert JH: The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis 2011, 11:333. BioMed Central Full Text
• [10]Ng’andwe C, Lowe JL, Richards PJ, Hause L, Wood C, Angeletti PC: The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis 2007, 7:77. BioMed Central Full Text
• [11]Moscicki A-B, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM: Prevalence of and risks for cervical Human Papillomavirus infection and squamous intraepithelial lesions in adolescent girls. Impact of infection with Human Immunodeficiency Virus. Arch Pediatr Adolesc Med 2000, 154:127-134.
• [12]Franceschi S, Jaffe H: Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 2007, 45:510-513.
• [13]Heard I: Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS 2009, 4:68-73.
• [14]Adler DH: The impact of HAART on HPV-related cervical disease. Curr HIV Res 2010, 8:493-497.
• [15]Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM: Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 2010, 5:e8634.
• [16]Memiah P, Mbuthia W, Kiiru G, Agbor S, Odhiambo F, Ojoo S, Biadgilign S: Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-Infected women in resource-limited settings. AIDS Res Treat 2012, 2012:953743.
• [17]Massad LS, Seaberg EC, Heather Watts D, Minkoff H, Levine AM, Henry D, Colie C, Darragh TM, Hessol NA: Long-term incidence of cervical cancer in women with Human Immunodeficiency Virus. Cancer 2009, 115:524-530.
• [18]WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre): Human papillomavirus and related cancers in Laos. Summary report 2010. Available at http://www.hpvcentre.net/ webcite
• [19]UNAIDS: Global AIDS response progress - country report, Lao PDR, 2012. Avalaible at http://www.aidsdatahub.org/Country-Profiles/Lao-PDR webcite
• [20]Kietpeerakool C, Phianmongkhol Y, Jitvatcharanun K, Siriratwatakul U, Srisomboon J: Knowledge, awareness, and attitudes of female sex workers toward HPV infection, cervical cancer, and cervical smears in Thailand. Int J Gynecol Obstet 2009, 107:216-219.
• [21]Lyimo FS, Bera TN: Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health 2012, 12:22. BioMed Central Full Text
• [22]Tebeu PM, Major AL, Rapiti E, Petignat P, Bouchardy C, Sando Z, de Bernis L, Ali L, Mhawech-Fauceglia P: The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of far North Province of Cameroon. Int J Gynecol Cancer 2008, 18:761-765.
• [23]Mbamara SU, Ikpeze OC, Okonkwo JE, Onyiaorah IV, Ukah CO: Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria. J Reprod Med 2011, 56:491-496.
• [24]Getahun F, Mazengia F, Abuhay M, Birhanu Z: Comprehensive knowledge about cervical cancer is low among women in Northwest Ethiopia. BMC Cancer 2013, 13:2. BioMed Central Full Text
• [25]Donati S, Giambi C, Declich S, Salmaso S, Filia A, Ciofi degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F, Collina N, Franchi D, Lattanzi A, Meda M, Minna MC, Nannini R, Gallicchio G, Bella A, PreGio Working group: Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine 2012, 30:2075-2082.
• [26]Massad LS, Evans CT, Wilson TE, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Levine AM, Watts DH, Weber KM: Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol 2010, 117:70-76.
• [27]Rabiu KA, Akinbami AA, Adewunmi AA, Akinola OI, Wright KO: The need to incorporate routine cervical cancer counselling and screening in the management of HIV positive women in Nigeria. Asian Pac J Cancer Prev 2011, 12:1211-1214.
• [28]Baranoski AS, Horsburgh CR, Cupples LA, Aschengrau A, Stier EA: Risk factors for nonadherence with Pap testing in HIV-infected women. J Womens Health 2011, 20:1635-1643.
• [29]Vu LTH, Bui D, Le HTT: Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign. BMC Cancer 2013, 13:53. BioMed Central Full Text
• [30]Ali SF, Ayub S, Manzoor NF, Azim S, Afif M, Akhtar N, Jafery WA, Tahir I, Farid-ul-Hasnian S, Uddin N: Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in Tertiary Care Hospitals in Karachi, Pakistan. PLoS One 2010, 5:e11059.
• [31]Giordano L, Webster P, Anthony C, Szarewski A, Davies P, Arbyn M, Segnan N, Austoker J: Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ Couns 2008, 72:130-136.
• [32]Kritpetcharat O, Wutichouy W, Sirijaichingkul S, Kritpetcharat P: Comparison of Pap Smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand. Asian Pac J Cancer Prev 2012, 13:5501-5504.
• [33]Boonmongkon P, Pylypa J, Nichter M: Emerging fears of cervical cancer in Northeast Thailand. Anthropol Med 1999, 6:359-380.
• [34]Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, Smith JS, Jiang CQ, Mei RB, Wang XG, Li ZA, Qiao YL: HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev 2012, 13:91-96.
• [35]Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, Eron J, Smith JS, Miller WC: High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: is targeted screening feasible? Cancer Epidemiol 2012, 36:263-269.
• [36]Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JSA, Parham GP: Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ 2008., 86(8) D–E
• [37]Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M, Levin S, Michelow P, Omar T, Hudgens MG, Williamson AL, Allan B, Lewis DA, Smith JS: Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One 2013, 8:e53494.